rs879253748
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The ENST00000393943.10(GABRA1):c.1200del(p.Lys401SerfsTer25) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
GABRA1
ENST00000393943.10 frameshift
ENST00000393943.10 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.612
Genes affected
GABRA1 (HGNC:4075): (gamma-aminobutyric acid type A receptor subunit alpha1) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.125 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-161897250-TC-T is Pathogenic according to our data. Variant chr5-161897250-TC-T is described in ClinVar as [Pathogenic]. Clinvar id is 242830.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr5-161897250-TC-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA1 | NM_001127644.2 | c.1200del | p.Lys401SerfsTer25 | frameshift_variant | 10/10 | ENST00000393943.10 | NP_001121116.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA1 | ENST00000393943.10 | c.1200del | p.Lys401SerfsTer25 | frameshift_variant | 10/10 | 1 | NM_001127644.2 | ENSP00000377517 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 19 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg | Jul 03, 2016 | The herewith reported de novo deletion of one base pair (c.1200del) in the last exon of GABRA1 is located downstream of the last splice junction and thus probably escapes nonsense-mediated mRNA decay. The variant is predicted to cause frameshifting and a premature translational stop codon (p.(Lys401Serfs*25)), changing or truncating the last 56 residues of the protein and thus lacking part of the intracellular loop between the last two transmembrane domains and the complete C-terminal transmembrane domain. In the literature, similar variants in GABRA1 and also in other GABA-A subunits have already been associated with disease. Functional studies for these variants could demonstrate a disrupted surface expression, hence leading to a change in subunit composition with reduction of GABA-A mediated inhibition resulting in a predisposition to seizures. Taken together the de novo status of the herewith identified GABRA1 variant c.1200del, the matching phenotype of the patient and the descriptions in the literature argue for the pathogenicity of this variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at